I’ve heard folks within the growing old subject describe GLP-1s as longevity medicine for some time now (even when they solely profit people who find themselves obese or diabetic within the first place). This newest announcement comes after we’ve seen a raft of different advantages related to taking these medicine. However there are additionally some bizarre negative effects.
Up to now, GLP-1 agonist medicine—which repress starvation—have been authorized for treating diabetes, continual kidney illness, and weight problems, they usually can be prescribed for some people who find themselves obese or liable to sure cardiovascular illnesses. However there may be analysis to recommend they may additionally assist folks with substance-use problems, they usually’ve been investigated for potential advantages in neurodegenerative illness and most cancers.
And a lot of persons are taking them. In response to a latest Gallup ballot, 11% of People are taking a GLP-1 drug for weight reduction, up from 3% in 2024. And 15% of People say they’ve used one for weight reduction sooner or later.
They are often extremely efficient. However, like all drug, they’ll include negative effects. And we’re nonetheless determining precisely what these may be, and the way widespread they’re.
The commonest negative effects are gastrointestinal—nausea, vomiting, diarrhea, and constipation. The medicine have additionally been linked to pancreatitis and gallstone illness.
Some declare that, in uncommon instances, the medicine may trigger harm to nerves behind the attention. Dozens of persons are suing Novo and Eli Lilly after growing a situation that may result in sudden imaginative and prescient loss. They’re claiming that their signs had been introduced on by the GLP-1 medicine that these corporations manufacture. Each corporations dispute the claims. Analysis into the hyperlink is blended.
We’re nonetheless attending to grips with the results of weight-loss medicine on hair and nails, too. When Savanna Vidal on the George Washington College Faculty of Medication and Well being Sciences in Washington, DC, and colleagues assessed digital well being knowledge from 67 US health-care organizations, they discovered that GLP-1 use was related to an elevated danger of hair loss. It’s nonetheless not regarded as frequent, nonetheless.
And at a convention in Austria final week, one other group offered the outcomes of a smaller examine suggesting that 66% of GLP-1 customers reported not less than one nail dysfunction—in some instances involving nail detachment. Nail situations had been additionally pretty frequent amongst individuals who didn’t take the medicine, although. The authors don’t declare that the medicine are inflicting nails to fall out (as I’m certain 11% of the American inhabitants will likely be relieved to listen to).




